These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8651818)

  • 1. Is the current system of staging lung cancer the best it can be?
    Wagner RB
    Ann Thorac Surg; 1996 Jun; 61(6):1877. PubMed ID: 8651818
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of surgical treatment of lung cancer involving the diaphragm.
    Riquet M; Lang-Lazdunski L
    J Thorac Cardiovasc Surg; 2001 Jun; 121(6):1224-6. PubMed ID: 11385409
    [No Abstract]   [Full Text] [Related]  

  • 3. New TNM classification for non-small-cell lung cancer.
    Tanoue LT; Detterbeck FC
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):413-23. PubMed ID: 19374596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of factors influencing the prognosis of lung cancer after surgery].
    Yin HN
    Zhonghua Wai Ke Za Zhi; 1984 Aug; 22(8):482-4, 511. PubMed ID: 6518911
    [No Abstract]   [Full Text] [Related]  

  • 5. [Extensive mediastinal staging in lung cancer--pro].
    Passlick B
    Dtsch Med Wochenschr; 2009 Mar; 134(11):522. PubMed ID: 19259909
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy for lung cancer in view of surgery].
    Tsuchiya R
    Kokyu To Junkan; 1993 Sep; 41(9):825-8. PubMed ID: 8210739
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrapulmonary metastasis in resected pathologic stage IIIB non-small cell lung cancer: possible contribution of aerogenous metastasis to the favorable outcome.
    Aokage K; Ishii G; Nagai K; Kawai O; Naito Y; Hasebe T; Nishimura M; Yoshida J; Ochiai A
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):386-91. PubMed ID: 17662777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of stage IIB lung cancer from the pathological factors].
    Tanaka T; Kaneda Y; Fujita N; Ueda K; Saeki K; Sakano H; Matsuoka T; Sudo M; Hayashi M; Zempo N; Esato K
    Kyobu Geka; 2001 May; 54(5):359-62; discussion 363-5. PubMed ID: 11357296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TNM staging system of lung carcinoma: historical notes, limitations and controversies].
    Motta G; Nahum MA; Testa T; Spinelli E
    Ann Ital Chir; 1995; 66(4):425-32. PubMed ID: 8686992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current aspects of a new staging classification of bronchial cancer and its clinical consequences].
    Vogt-Moykopf I; Branscheid D; Bülzebruck H; Probst G
    Chirurg; 1989 Jan; 60(1):16-23. PubMed ID: 2920616
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of TNM classification for lung carcinoma with satellite nodules in the same lobe as the primary].
    Sakata S; Kawashima O; Ibe T; Otani Y; Kamiyoshihara M; Sugano M; Nakajima T; Morishita Y
    Kyobu Geka; 2000 Oct; 53(11):926-8. PubMed ID: 11048443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heterogeneity of locally advanced lung cancer; adequacy and controversy in TNM staging].
    Horinouchi H; Kobayashi K; Kawamura M; Watanabe M; Sawafuji M; Inoue Y
    Nihon Rinsho; 2002 May; 60 Suppl 5():245-9. PubMed ID: 12101666
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung cancer: new staging system and prognosis].
    Li C; Zhang R
    Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):189-91. PubMed ID: 11832024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis.
    Wisnivesky JP; Henschke C; McGinn T; Iannuzzi MC
    Lung Cancer; 2005 Aug; 49(2):181-6. PubMed ID: 16022911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in patients with pathological and N2 non-small cell lung cancer.
    Saito M; Kato H
    Ann Thorac Cardiovasc Surg; 2008 Feb; 14(1):1-2. PubMed ID: 18292731
    [No Abstract]   [Full Text] [Related]  

  • 17. Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
    Weisenburger TH; Graham MV; Sause WT; Byhardt RW; Curran WJ; Fuller D; Ko B; Komaki R; Kaiser LR; Leibel SA
    Radiology; 2000 Jun; 215 Suppl():1295-318. PubMed ID: 11037548
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
    Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
    Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance of intrapulmonary metastases in cases of surgically treated lung cancer].
    Szöke T; Troján I; Furák J; Tiszlavicz L; Balogh A
    Magy Onkol; 2003; 47(4):397-401. PubMed ID: 14716437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.